Zosano Pharma Corp (ZSAN)

0.6216 -0.01  -1.99% NASDAQ Oct 18, 16:00 0.6216 0.00  0.00% After-Hours: 19:01 USD
View Full Chart
Price Chart
View All ZSAN News


View All Events


Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/10/2021 Earnings Results Q2 2021 Earnings Results
06/10/2021 11:30 EST AGM 2020 Annual General Meeting
05/12/2021 Earnings Results Q1 2021 Earnings Results
03/11/2021 Earnings Results Q4 2020 Earnings Results
11/13/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Zosano Pharma Corp is a clinical-stage biopharmaceutical company. It is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using the proprietary transdermal microneedle system. The system is designed to facilitate rapid drug absorption into the bloodstream, which can result in an improved pharmacokinetic profile compared to original dosage forms. The company's operating segment is to develop human pharmaceutical products. Its primary product candidate is Qtrypta (M207) which is the proprietary formulation of zolmitriptan delivered utilizing the system.
  • URL: http://www.zosanopharma.com
  • Investor Relations URL: http://ir.zosanopharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.